Neuroimaging of Treatment-Related Conditions in the Brain
- Publisher's listprice EUR 149.79
-
58 507 Ft (55 721 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 11 701 Ft off)
- Discounted price 46 806 Ft (44 577 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
51 486 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Springer Nature Switzerland
- Date of Publication 19 June 2026
- ISBN 9783032236173
- Binding Hardback
- No. of pages240 pages
- Size 254x178 mm
- Language English
- Illustrations II, 240 p. 122 illus., 34 illus. in color. 700
Categories
Long description:
This book presents the neuroimaging features of the most common conditions related or triggered by therapies for several medical conditions. In the majority of cases, these therapies are mandatory and unavoidable, but it is important to be aware of the potential complications and to identify, diagnose, report and follow-up the main neuroradiological hallmarks of these conditions. Some of these may be underreported, as for example the long-term consequences of radiation therapy, and some are less known, as SMART syndrome. Many conditions may have a broad differential diagnosis and it is not trivial to distinguish a treatment-related component from a spontaneous disease in some cases (PRES or RCVS, ARIA, etc.). Regarding PRES and RCVS, being numerous the treatments potentially associated, a description based on neuroimaigng and to detail the associated drugs is offered within the chapter. Immunotherapy is a new and modern treatment where cerebral complications are present and the increased incidence depends on the increased use of these strategies for many diseases, ranging from neurological and systemic immuno-mediated diseases to Alzheimer's disease to solid and hematologic tumors.
Due to the multidisciplinary nature of its contents, the book is addressed to neuroradiologists, radiologists, radiotherapists, neurologists, rheumatologists, oncologists, and hematologists.
Table of Contents:
1. ENCEPHALOPATHY: DEFINITION AND DIAGNOSTICA CRITERIA.- 2. NEUROIMAGING FEATURES OF ENCEPHALOPATHY.- 3. LONG-TERM POST-RADIATION INJURY OF THE CENTRAL NERVOUS SYSTEM. NEURORADIOLOGICAL CLUES FOR DIAGNOSIS.- 4. SMART SYNDROME: CLINICAL AND NEUROIMAGING CLUES OF AN UNDERRECOGNIZED IATROGENIC DISEASE.- 5. DILEMMAS IN NEUROIMAGING OF BRAIN TUMORS: PSEUDOPROGRESSION OR RECURRENCE.- 6. PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY IN IMMUNOTHERAPY.- 7. AMYLOID-RELATED IMAGING ABNORMALITIES (ARIA) IN IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE.- 8.POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME: CLINICAL AND NEUROIMAGING CLUES IN DRUGS-TRIGGERED CASES.- 9. TREATMENT-RELATED REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME.- 10. CAR-T THERAPY AND NEUROTOXICITY.- 11. DIALYSIS-RELATED ENCEPHALOPATHY.- 12. CONTRAST-RELATED ENCEPHALOPATHY.-13. IATROGENIC WERNICKE’S ENCEPHALOPATHY.- 14. BRAIN INVOLVEMENT DURING THERAPY WITH IMMUNOLOGIC CHECK POINT INHIBITORS.
More
